Domestic pharmaceutical firms' strategic alliance with multinational firms up

Published: 2003-10-09 07:00:00

Updated: 2003-10-09 07:00:00

Under the ongoing system of separating drug dispensing from medical practice, the trend of strategic alliances between and domestic and foreign-invested pharmaceutical firms is expected to accelerate riding high, as such strategic tie-ups have had positive impact on the sales of individual items....

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK